Sichuan Biokin Pharmaceutical Co.,Ltd. (SHSE: 688506)
Health Care · Pharmaceuticals · CN
CN¥242.00
+1.13% today · -34.0% 1Y
Sichuan Biokin Pharmaceutical Co.,Ltd. (SHSE: 688506) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.90B.
Over the last twelve months the share price has lost 34.0%, trading between 200.10 and 404.00.
Tweenvest scores Sichuan Biokin Pharmaceutical Co.,Ltd. across four factors: quality 51/100, value 57/100, growth 0/100. Its strongest factor is value.
688506 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.90B
- Revenue (TTM)
- $373.37M
- P/E
- —
- EPS
- -3.84
- Dividend yield
- —
- Beta (5Y)
- -0.05
- 52-week high
- CN¥404.00
- 52-week low
- CN¥200.10
- Avg volume (3M)
- —
- Shares outstanding
- 412.87M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Royalty Pharma plcNasdaqGS: RPRX | $25.27B | $56.21 | -0.97% |
| Viatris Inc.NasdaqGS: VTRS | $20.09B | $17.44 | -0.29% |
| Torrent Pharmaceuticals LimitedBSE: 500420 | $18.81B | Rs4,761.95 | -4.47% |
| Jazz Pharmaceuticals plcNasdaqGS: JAZZ | $15.01B | $222.45 | -3.78% |
| Shionogi & Co., Ltd.TSE: 4507 | $14.86B | ¥2,762.50 | -0.02% |
| CSPC Pharmaceutical Group LimitedSEHK: 1093 | $14.28B | HK$9.82 | -1.85% |
| Yunnan Baiyao Group Co.,LtdSZSE: 000538 | $13.42B | CN¥50.44 | +1.14% |
| Ipsen S.A.ENXTPA: IPN | $13.31B | €141.50 | -2.41% |
Figures last refreshed Oct 4, 2026.